311
Views
12
CrossRef citations to date
0
Altmetric
Original Research

Comparative effect of canrenone or hydrochlorothiazide addition to valsartan/amlodipine combination on urinary albumin excretion in well-controlled type 2 diabetic hypertensive patients with microalbuminuria

, , , , &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Giuseppe Derosa, Giovanni Gaudio, Gianfranco Pasini, Angela D’Angelo & Pamela Maffioli. (2018) A randomized, double-blind clinical trial of canrenone vs hydrochlorothiazide in addition to angiotensin II receptor blockers in hypertensive type 2 diabetic patients. Drug Design, Development and Therapy 12, pages 2611-2616.
Read now
Decio Armanini, Chiara Sabbadin, Gabriella Donà, Giulio Clari & Luciana Bordin. (2014) Aldosterone receptor blockers spironolactone and canrenone: two multivalent drugs. Expert Opinion on Pharmacotherapy 15:7, pages 909-912.
Read now

Articles from other publishers (10)

Maria-Eleni Alexandrou, Marieta P. Theodorakopoulou & Pantelis A. Sarafidis. (2022) Role of Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease. Kidney and Dialysis 2:2, pages 163-182.
Crossref
Edmund YM Chung, Marinella Ruospo, Patrizia Natale, Davide Bolignano, Sankar D Navaneethan, Suetonia C Palmer & Giovanni FM Strippoli. (2020) Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progression of chronic kidney disease. Cochrane Database of Systematic Reviews 2020:10.
Crossref
Jill J. Hall, Dean T. Eurich, Danielle Nagy, Lisa Tjosvold & John-Michael Gamble. (2020) Thiazide Diuretic–Induced Change in Fasting Plasma Glucose: a Meta-analysis of Randomized Clinical Trials. Journal of General Internal Medicine 35:6, pages 1849-1860.
Crossref
Maria-Eleni Alexandrou, Aikaterini Papagianni, Apostolos Tsapas, Charalampos Loutradis, Afroditi Boutou, Alexia Piperidou, Dorothea Papadopoulou, Luis Ruilope, George Bakris & Pantelis Sarafidis. (2019) Effects of mineralocorticoid receptor antagonists in proteinuric kidney disease. Journal of Hypertension 37:12, pages 2307-2324.
Crossref
Davide Soranna, Antonella Zambon, Giovanni Corrao, Alberto Zanchetti, Gianfranco Parati & Giuseppe Mancia. (2019) Different effects of antihypertensive treatment on office and ambulatory blood pressure. Journal of Hypertension 37:3, pages 467-475.
Crossref
Sandra Korol, Fannie Mottet, Sylvie Perreault, William L. Baker, Michel White & Simon de Denus. (2017) A systematic review and meta-analysis of the impact of mineralocorticoid receptor antagonists on glucose homeostasis. Medicine 96:48, pages e8719.
Crossref
Farheen K. Dojki & George Bakris. (2017) Nonsteroidal mineralocorticoid antagonists in diabetic kidney disease. Current Opinion in Nephrology and Hypertension 26:5, pages 368-374.
Crossref
Giuseppe Derosa, Pamela Maffioli, Maria D'Avino, Carla Sala, Amedeo Mugellini, Vito Vulpis, Salvatore Felis, Luigina Guasti, Riccardo Sarzani, Alessandro Bestetti, Massimo Vanasia & Giovanni Gaudio. (2017) Efficacy and safety of two dosages of canrenone as add-on therapy in hypertensive patients taking ace-inhibitors or angiotensin II receptor blockers and hydrochlorothiazide at maximum dosage in a randomized clinical trial: The ESCAPE-IT trial. Cardiovascular Therapeutics 35:1, pages 47-54.
Crossref
Rongzhong Huang, Yuxing Feng, Ying Wang, Xiaoxia Qin, Narayan Dhruvaraj Melgiri, Yang Sun & Xingsheng Li. (2017) Comparative Efficacy and Safety of Antihypertensive Agents for Adult Diabetic Patients with Microalbuminuric Kidney Disease: A Network Meta-Analysis. PLOS ONE 12:1, pages e0168582.
Crossref
Pingping Yang, Tianlun Huang & Gaosi Xu. (2016) The novel mineralocorticoid receptor antagonist finerenone in diabetic kidney disease: Progress and challenges. Metabolism 65:9, pages 1342-1349.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.